Inventor · disambiguated record
Vincenzo Re
Also filed as: RE VINCENZO
1 granted patent·12 pending applications·0 citations·filing 2003–2010
13Inventor score
Top patents by PatentIndex Score
13 records- 0163US2007281023A1Pharmaceutical composition for modified release insulin sensitiserSMITHKLINE BEECHAM P L C & SMI·Filed 2007·Application pending·0 cites
- 0257US2004091531A1Novel composition and useSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0357US2008014266A1Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agentSMITHKLINE BEECHAM PLC·Filed 2007·Application pending·0 cites
- 0455US2003153607A1Novel composition and useSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0555US2005136111A1Novel composition and useSMITHKLINE BEECHAM P L C AND S·Filed 2005·Application pending·0 cites
- 0653US2006263425A1Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agentSMITHKLINE BEECHAM PLC·Filed 2006·Application pending·0 cites
- 0750US2004081697A1Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agentSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0843US2007141146A1Novel compositionsSMITHKLINE BEECHAM PHARMCO PUE·Filed 2004·Application pending·0 cites
- 0940US2005175700A1Oral dosage form for controlled drug releaseFiled 2003·Application pending·0 cites
- 1037US9144547B2Oral dosage form for controlled drug releaseLI CHI LEUNG·Filed 2010·Granted Sep 29, 2015·0 cites·8 claims
- 1136US2007134326A1Composition for releasing a weak base for an extended period of timeHOKE JOHN F·Filed 2004·Application pending·0 cites
- 1231US2008166408A1Oral Dosage Form Comprising RosiglitazoneHEAFIELD JOANNE·Filed 2006·Application pending·0 cites
- 1319US2008139624A1Oral Dosage Form Comprising RosiglitazoneRE VINCENZO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincenzo Re files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →